Explore All AccessOnkologie : Impact Factor & More
pISSN: 0378-584X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Onkologie Key Metrics
CiteScore 
0.05
H-Index
3
Indexed in the following public directories
CrossRef
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Onkologie
PharmaNews
- 16 May 2025
- Oncology Research and Treatment
PharmaNews
- 16 May 2025
- Oncology Research and Treatment
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC
- 16 May 2025
- Oncology Research and Treatment
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab
- 16 May 2025
- Oncology Research and Treatment
Society Bulletins
- 16 May 2025
- Oncology Research and Treatment
Additional immunotherapy to standard of care for unresectable locally advanced head and neck squamous cell carcinoma: a meta-analysis.
- 15 May 2025
- Oncology research and treatment
PharmaNews
- 16 May 2025
- Oncology Research and Treatment
PharmaNews
- 16 May 2025
- Oncology Research and Treatment
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC
- 16 May 2025
- Oncology Research and Treatment
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab
- 16 May 2025
- Oncology Research and Treatment
Society Bulletins
- 16 May 2025
- Oncology Research and Treatment
Additional immunotherapy to standard of care for unresectable locally advanced head and neck squamous cell carcinoma: a meta-analysis.
- 15 May 2025
- Oncology research and treatment
